Patanjali moves Delhi HC against ban on ads targeting Dabur Chyawanprash
- byDoctor News Daily Team
- 17 September, 2025
- 0 Comments
- 0 Mins

New Delhi: Following the Delhi High Court directive restraining itfrom running''disparaging'' advertisements against Dabur Chyawanprash, Yoga guruRamdev'sPatanjali Ayurved has filed a plea challenging the order. The petition, which is likely to come up for hearing on Friday before a division bench of Justices C Hari Shankar and Om Prakash Shukla, has challenged the July 3 order, which said that a strong prima facie case of disparagement was apparent in both TV and print ads. In the July order, Justice Mini Pushkarna allowed an interim injunction on Dabur's plea and directedPatanjalito delete the line "Why settle for ordinary chyawanprash made with 40 herbs?" from print advertisements and modify it accordingly in Hindi, news agency PTI reported. Also Read:Chhattisgarh Police file closure report in Ramdev Allopathy case, SC Told She also directed Patanjali to delete the line "Jinko Ayurved or Vedon ka gyan nahi Charak, Sushrut, Dhanvantri aur Chyawanrishi Ki Parampara ke Anuroop, original chyawanprash kaise bana payenge?" from its advertisement. Patanjali was further directed to delete the line "Toh ordinary chyawanprash kyu?". The bench said Patanjali shall be allowed to run the print and TV advertisements after the modifications. In its petition,Patanjalihas claimed before the court that its commercial made no reference to Dabur. The judge noted in the July 3 order that the TV commercial (TVC) was narrated by Ramdev, an acknowledged yoga and Vedic expert, who appeared in person in the advertisement. The narrative of the commercial assumes more importance coming from the mouth of a person popularly known to be an expert in the field, the judge said. The said statements in the commercial, in addition to being false, were also misleading for the reason that the impression created by Patanjali, with Ramdev as the brand ambassador, was that only the defendants had the knowledge of Ayurveda and Vedas and hence could make chyawanprash as per the traditions. There is no requirement for a manufacturer to have knowledge of Ayurveda and Vedas to make chyawanprash, the bench said. The petition filed by Dabur before the single judge bench alleged "Patanjali Special Chyawanprash" was "disparaging Dabur Chyawanprash specifically" and chyawanprash in general, by claiming that "no other manufacturer has the knowledge to prepare chyawanprash" -- constituting generic disparagement, reports PTI. It further claimed that the advertisement used the prefix "ordinary" with respect to all other chyawanprash, denoting that they were "inferior". The advertisement also made "untrue" claims that all other manufacturers had no knowledge of Ayurvedic texts and the formulae used to prepare chyawanprash, it said. Also Read:Kerala Court issues bailable warrant against Baba Ramdev, MD Balakrishna in misleading ads case
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
AI Reads Mammograms to Predict Heart Disease Risk...
- 18 September, 2025
Study Reveals Mediterranean Diet Reduces Gum Infla...
- 18 September, 2025
Lower Irisin Levels Linked to Diabetic Nephropathy...
- 18 September, 2025
Androgenic anabolic steroids exposure associated w...
- 18 September, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!